IMPLANT SITE DISCOLOURATION

IMPLANT SITE DISCOLOURATION was reported 154 times

These drug classes are most commonly taken by patients reporting IMPLANT SITE DISCOLOURATION:

# Drug Count
0 Progestin [EPC] 119
1 Androgen [EPC] 6
2 gamma-Aminobutyric Acid-ergic Agonist [EPC] 6
3 Anti-epileptic Agent [EPC] 2
4 Nonsteroidal Anti-inflammatory Drug [EPC] 2
5 Osmotic Laxative [EPC] 2
6 Platelet Aggregation Inhibitor [EPC] 2
7 Proton Pump Inhibitor [EPC] 2
8 Provitamin D2 Compound [EPC] 2
9 Aldosterone Antagonist [EPC] 1
10 Amide Local Anesthetic [EPC] 1
11 Antiarrhythmic [EPC] 1
12 Antiseptic [EPC] 1
13 Aromatase Inhibitor [EPC] 1
14 Arteriolar Vasodilator [EPC] 1
15 Atypical Antipsychotic [EPC] 1
16 Benzodiazepine [EPC] 1
17 Calcineurin Inhibitor Immunosuppressant [EPC] 1
18 Catecholamine [EPC] 1
19 Central alpha-2 Adrenergic Agonist [EPC] 1
20 Corticosteroid [EPC] 1
21 Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] 1
22 Epidermal Growth Factor Receptor Antagonist [EPC] 1
23 Expectorant [EPC] 1
24 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
25 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
26 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1
27 Macrolide Antimicrobial [EPC] 1
28 Macrolide [EPC] 1
29 Opioid Agonist [EPC] 1
30 Polyene Antifungal [EPC] 1
31 Progestin-containing Intrauterine System [EPC] 1
32 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
33 Vitamin C [EPC] 1
34 alpha-Adrenergic Agonist [EPC] 1
35 beta-Adrenergic Agonist [EPC] 1
36 beta-Adrenergic Blocker [EPC] 1